Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France - S. Dalle; P. Saiag; C. Lebbé; J.-J. Grob; B. Dréno; S. Dalac; B. Asselain; F. Skowron; S. Darras; N. Jovenin; G. Quereux; A. Khammari; et al. (EJC Skin Cancer)